chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient experienced heavy flows of a runny nose for the two weeks following her second vaccine dose. Initially thought nothing of it but they persisted and did not stop for two weeks. Nosebleeds stopped on their own without any medical attention.
This spontaneous report was received from a pharmacists and refers to an unknown number of patients of an unknown gender and age. On an unspecified dates, an unknown number of patients were inadvertently administered RECOMBIVAX HB (injection, dose, frequency, lot # and expiration date not reported) that had been improperly stored. No adverse effects were reported. Additional information has been requested.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Jan2021 at 12:00 as dose 1, single (Lot number: EN5318), in left arm, on 17Feb2021 at 13:00 as dose 2, single (Lot number: EL9266), in left arm and on 27Oct2021 at 12:00 as dose 3 (booster), single (Lot number: EW0181) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "congestive heart failure" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "Afib" (unspecified if ongoing); "PVC" (unspecified if ongoing), notes: other medical history:PVC; "Grass allergy" (unspecified if ongoing); "mountain cedar allergy" (unspecified if ongoing), notes: known allergies:mountain cedar. Concomitant medication(s) included: L-THYROXINE [LEVOTHYROXINE], start date: Mar2000; LISINOPRIL, start date: Oct2020; METOPROLOL, start date: Mar2010. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19 included Paxlovid .; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported events Drug ineffective , suspected covid-19 cannot be completely excluded based on temporal association.
Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. No adverse events were reported. Vial did not undergo any temperature excursion. Vial was placed in refrigerator on 31-Oct-2021.  No treatment medications were reported.
Swollen throat, burning eyes, cough, headache, muscle aches, mucous in eyes, dizziness, vomiting.
After administered pt's first dose of the Covid vaccine, pt reported a racing heart. I took pt?s vitals 156/96 and pulse of 156. No other symptoms. Pt reported taking a Xanax right before injection but didn?t feel anxious while I was speaking with her. Per pt, no history of htn or tachycardia and BP usually runs around 120/80.They took vitals, did an ekg , the MD assessed the pt. After extra time of observation and more vitals pt was discharged accompanied by family member ambulating without assistance. Per RN, before she left pulse was at 97 and BP was normal.
No adverse event/ No known pt adverse reactions; Indavertently administered improperly stored GARDASIL 9/ Temps went out of range. Vaccines given despite temp excursion.; This spontaneous report was received from a licensed practical nurse (L.P.N.) regarding a 12-year-old male patient. The patient's medical history included vaccination with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (one previous dose) and influenza vaccine (FLUZONE [INFLUENZA VACCINE]) (two previous doses). His concurrent conditions, concomitant therapies, drug reactions, and allergies were not provided.  On 12-JAN-2022, the patient was vaccinated with improperly stored: second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot number U007667, with an expiration date of 23-MAY-2023, intramuscularly (dose, strength and formulation were not reported) for prophylaxis and with the third dose of influenza vaccine (FLUZONE [INFLUENZA VACCINE]) lot number: UT7317JA, expiry date: 30-JUN-2022, intramuscularly (dose, strength and formulation were not reported) for prophylaxis (product storage error). There were no additional adverse event (no adverse event). Administered dose of vaccine experienced the temperature excursion of 27.2 degrees Fahrenheit (F) and 49.8 F for 8 hours 30 minutes and 21 hours and 15 minutes, respectively. There were no previous excursions reported. Digital data logger was involved. As of 18-FEB-2022, additional information had been requested.  This is one of nine reports received from the same reporter. ; Sender's Comments:  US-009507513-2202USA007811: US-009507513-2202USA007814: US-009507513-2202USA007815: US-009507513-2202USA007816: US-009507513-2202USA007818: US-009507513-2202USA007812: US-009507513-2202USA002574: US-009507513-2202USA007813:
As I said, with the second vaccine, I started having little bruises on my legs, chest and breasts without any kind of injury and they were showing up without any kind of impact. I had one or two last week as well, they are fairly small. The other thing, as I mentioned, I noticed after a showered, a prominent blood vessel that showed in my left arm from my chest - a horizontal line that connected basically. I then noticed blood vessels in my left breast as well. Also, at the right temple by my right eye brow which is there all the time now. Two weeks ago there was another blood vessel that went from the top of my hairline to my nose. I ran a fever for about three days after the second vaccine as well and felt very run down for about three to four days. My vaccine was 3/31/2021. I had a telehealth appointment with my DR on 4/21/2021 and they recommended different medications which turns out I couldn't use for various reasons. They are going to do some PCR testing on me with Microgen. Also I developed stomach problems, I forgot about that, I am seeing my notes here. On April 14, 2021 I developed esophageal spasms too and had to see a nurse practitioner. I had a problem with my thyroid pill as well, I would take my pill in the morning, and because of my stomach problems, they cut my Levoxyl dose down because I would get very shaky after taking it.
approx 10min p/vax pt became dizzy, weak, very pale, clammy, BP 80/40, P40, R20;pt was alert w/no resp distress;called 911;EMT arrived;did full assessment;pt recovered;
Patient says that he developed the expected muscle soreness from the injection but that it did not go away after 3 days.  He claims that his arm is still sore (he likens it to a rotator cuff injury).  The pain has not increased from the original soreness.  He claims that the soreness goes away but comes back when he touches his arm or he sleeps on his arm.  He reports no swelling, no fever, and no discoloration of the arm or around the injection site.  He has not had any recent illnesses (nor before the vaccine) and did not have any recent vaccines prior to the flu shot.  He reports that he has not yet seen a physician regarding the soreness.  His reaction was brought to our attention by his friend who was vaccinated at the same time and reports a similar reaction (VAERS E-report number E-76990).  He says his only treatment thus far has been to ice his arm.
Drug ineffective; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Heart attack", start date: 2007 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: Patient was treated with Paxlovid from 29Mar2023 to 03Apr2023. Lot for dose 3 was misplaced or discarded. There were no Known allergies.  The information on the batch/lot number for BNT162B2, BNT162B2 OMI BA.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300148662 same patient, different product/event;
patient under 16 years of age who received 1st dose of COVID19 vaccine on 12FEB21.  patient was 15 years and 9 months at time of vaccination.    NOTE: ample information available to patient/guardian on vaccine including  FACT SHEET FOR RECIPIENTS AND CAREGIVERS; as well as local screening  form which has patient/caregiver sign the following statement: "I have read or had explained to me the information in the Coronavirus Vaccine Emergency Use Authorization (EUA) Fact Sheet. I have also had a chance to ask questions, and they were answered to my satisfaction".   Patient/Guardian attempted to make an appointment for 2nd dose;  Appointment line clerk was able to screen patient and advice that patient was not eligible for vaccination per manufacturer recommendation and EUA authorization.   Officer in charge of site attempted to contact parent/guardian but upon attempts only was able to leave voice messages.  Parent/guardian given a  number for callback.  at the time of this report no callback was received.
Rash at the injection site; Rash at the injection site and it is also itchy; Second dose received outside of window; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Rash at the injection site and it is also itchy) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received outside of window) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received outside of window). On 27-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PRURITUS (Rash at the injection site and it is also itchy). On 21-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received outside of window) had resolved. At the time of the report, VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PRURITUS (Rash at the injection site and it is also itchy) had not resolved. Not Provided
Day 1 (11/25) - noticed a golf ball sized welt in my left SQ space with redness surrounding the injection site, swelling in my dorsal left arm near my armpit, heat in the injection area, and notable pain upon palpation  Day 2 (11/26) - noticed the welt slowly getting larger but opted to wait and ice/use ibuprofen to manage the symptoms after researching common reactions from Pneumovax 23  Day 3 (11/27) - woke up in the morning with tennis ball sized swelling and the same symptoms as before except the redness had spread and become deeper, chose to call a triage line and was told to mark the redness with a sharpie, continue supportive care, and be seen in the ER if the redness spreads at all or if the swelling does not go down by tomorrow; ended up going to the ER later that night (10 PM) due to increased heat and swelling and severe pain upon just touching the area but the ER doctor said it was a normal reaction at this point and sent me home with supportive care and instructions to return if it did not spontaneously resolve in 1 week or 3-4 days after the vaccination (the discharge instructions stated both, so not sure which was correct)  Day 6 (11/30) - swelling had continued to progress along with redness and never resolved, ice/ibuprofen/heat/Tylenol were not effective in managing swelling or pain, at this point the swelling was as hard as a rock and the size of a softball, redness had spread about halfway to the elbow, heat was still present, pain was unbearable and increased drastically upon palpation to the point that if the site was pushed or bumped hard enough the entire arm would go numb and I would collapse; chose to go to a different ER at this point in which I was immediately rushed to ultrasound for imaging which revealed severe edema ribboned throughout the swelling continuing all the way down the arm, I was sent home on oral antibiotics for now and given strict instructions to monitor for any symptoms of systemic infection or spreading as well as to return if anything should change, also told to follow up with a primary care provider tomorrow for further diagnostics and follow up treatments, began first dose of antibiotics around 7 PM this night   Day 7 (12/1) - woke up and took 2nd dose of antibiotics, would has still progressed and is a similar size, the skin around the wound is painful to the touch and tight feeling like it is pinched, there is significant bruising all the way down to my elbow and the redness is beginning to ribbon down to my elbow as well, I am going into the doctor this afternoon again for follow up
Received Anthrax vaccine on left upper arm on 8 Mar 03.  Developed increasing redness, warmth and discomfort at injection site.  Redness spread up to 6"x3" below injection site.  Some induration and swelling at erythematous site.  Itching & fever-like symptoms relieved by Benadryl.
I had my first covid vaccine 12/22/20.  On 12/24/20 I noticed I could not see as well as normal with my RIGHT eye.  I had a sore left arm and headache, which I attributed to the vaccine.  By 12/27/20, I called the emergency number at my primary ophthalmologist as was seen.  They thought I had a posterior vitreous detachment and asked me to see my primary eye doctor in a week.  By 12/30/20 I could not see to work and called the eye doctor and they decided I should see my retinal specialist who deals with problems with my left eye.  He could see nothing to explain my decreased acuity and told me to keep my follow up at the other office.  I saw a Dr on 1/4/21, who takes care of my left eye cataract and glaucoma.  He called in an associate.  My vision had further declined and they thought I had ocular neuritis.  I couldn't see the big E on the eye chart at all at my worst.  I was scheduled for an MRI of the head, which showed ocular neuritis in my right eye.  Dr assumed care and I started IV steroids on 1/13 for 3 days, followed by oral prednisone taper.  I also was referred to a neurologist to rule out MS.  I saw Dr. 1/28/21.  After the steroids, my vision improved, but I still can't work or drive.  Neurologist does not think I have MS and is ruling out NMO but doesn't think I have that either.
sore arm; This is a spontaneous report from a contactable consumer (reporting for her mother). This consumer reported similar events for 2 patients. This is second of 2 reports.  A female patient (Age: 97, Units: unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no side effects at all, just the sore arm. The patient was due for the second shot next Thursday. The reporter asked what the odds were of having side effects from the second shot. The clinical outcome of sore arm was unknown.   Information of lot/batch number has been requested.; Sender's Comments: Linked Report(s) same reporter, drug, event, different patient
Mom incorrectly filled out consent form with older child's date of birth showing that child was 10 and not 4.  two older siblings in the exam room with 4yr old, all receiving covid doses.  Pt accidentally  received the 5-11 Orange Bivalent dose instead of the 6mo-4y Maroon dose #3.
golf ball size swelling and redness to injection site. Non tender. Pt afebrile. Pt to see pediatrician today.
03/21/08 patient came to clinic, complained of mid-sternal chest discomfort.  Sent to hospital ER for evaluation.
terrible case of diarrhea; arm is sore; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3749), intramuscular on 20Jan2021 15:30 at a single dose on left arm for COVID-19 immunization. Medical history included ongoing COPD, diagnosed probably 7 years ago. There were no concomitant medications. The patient's arm began to get sore the day after receiving the vaccine, 21Jan2021. She had a CAT scan earlier last week, but this was prior to the vaccine. She had the terrible case of diarrhea this morning, 22Jan2021, but she hasn't had diarrhea since then. She got up this morning. She was feeling fine, she drank 2 cups of coffee. She was pouring herself a cup of orange juice, and she had a terrible case of diarrhea. The outcome of the event diarrhea was unknown, arm is sore was recovering. Vaccination Facility Type was Physician's office. Adverse events did not require a visit to Emergency Room nor Physician Office. No prior vaccinations (within 4 weeks). No adverse events following prior vaccinations.
seizure; hospital staff "couldn't wake him up"; A spontaneous report was received from a consumer who was also a 77-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a seizure. He was hospitalized for one night and the staff had a difficult time waking him up.   The patient's medical history included prostate cancer last year. Patient provided that he takes 8 or 10 different medications daily but did not list them out. No other medical history was shared and patient has no known drug or food allergies.   On 30-Jan-2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 042L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 31-Jan-2021, the day after the mRNA-1273 vaccine was given, the patient had a seizure and was hospitalized for one night. He stated that the hospital staff had a hard time waking him up. He spent one night in the hospital and was released on 01-Feb-2021. It was not reported what caused the seizure and the patient was unsure if the hospital knew that he had the vaccination the day prior. He was discharged with Keppra.  Consent to contact was given by the patient to contact him and the hospital.  No further treatment information was not provided.   Action taken with mRNA-1273 was not reported.  The events, seizure and depressed consciousness level, were considered resolved on 01 Feb 2021.; Reporter's Comments: Very limited information regarding these events have been provided at this time. Further information has been requested.
Pt came in office for 3 yr check-up. Received flu vaccine. 10 mins later child started complaining eye's hurt than mouth. Seen at ER BENADRYL and Prednisolone was given and prescribed.
clothing rubbing on her arm bothered it; rash; itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE IRRITATION (clothing rubbing on her arm bothered it), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itchy) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE IRRITATION (clothing rubbing on her arm bothered it), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 27-Feb-2021, INJECTION SITE IRRITATION (clothing rubbing on her arm bothered it), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were reported.
seizures; Product origin unknown; This spontaneous report as received from a consumer concerning a female patient of unknown age.    There was no information about the patient's medical history, concurrent conditions or concomitant medication On 16-OCT-2020, the patient was vaccinated with an unspecified dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(manufacturer unknown) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown) for prophylaxis (dose, route of administration, lot number and expiration date were not reported). The reporter did not specify (and likely did not know) which HPV vaccine, the patient received It was reported that the patient started having seizures soon after she received hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(manufacturer unknown) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine  (manufacturer unknown) reported as " HPV vaccine", on the same date. The causal relationship between the event of seizures and therapy with: hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(manufacturer unknown) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown) were not reported. Upon internal review the event of  seizures was considered to be medically significant.
After getting the shot, pt had a local reaction of redness and swelling, flu-like symptoms, and decreased oxygen levels. He is no longer having these side effects.